✦ LIBER ✦

Cost effectiveness of adalimumab in the treatment of patients with moderate to severe rheumatoid arthritis in Sweden

✍ Scribed by Bansback, N J

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS21 COST—EFFECTIVENESS OF RITUXIMAB VS

✍ LA Bynum; N Joshi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Cost-effectiveness of adalimumab, etaner

✍ Soini, E. J.; Hallinen, T. A.; Puolakka, K.; Vihervaara, V.; Kauppi, M. J. 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 418 KB

PAR5 COST-EFFECTIVENESS OF ADALIMUMAB (H

✍ N Bansback; A Brennan; N Sengupta 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

Indirect cost-effectiveness analyses of

✍ Yuan, Yong; Trivedi, Digisha; Maclean, Ross; Rosenblatt, Lisa 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 488 KB

Cost-effectiveness of abatacept in patie

✍ Vera-Llonch, M.; Massarotti, E.; Wolfe, F.; Shadick, N.; Westhovens, R.; Sofrygi 📂 Article 📅 2007 🏛 Oxford University Press 🌐 English ⚖ 134 KB

PMS30 Cost-Effectiveness of Tocilizumab

✍ A. Diamantopoulos; S. Andrade; A. Bernardo; J. Branco; L. Inês; J.A. Pereira da 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB